Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Healthy weight loss should not feel extreme
Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease and is associated with significant cardiovascular morbidity and mortality
Known gastroparesis or severe functional dyspepsia History of pancreatitis (particularly unexplained) Active gallbladder disease or prior complications Severe IBS-C unresponsive to standard measures Significant reflux worsened by delayed emptying Planned procedures under sedation/general anesthesia (coordinate care) These arent automatic nos, but they do call for individualized riskbenefit discussions
If successful, it could weaken Lillys exclusivity and open the door for broader compoundingregardless of FDA shortage status
You get the maximum benefit without the side effects
However, potential side effects, cost considerations, and the need for long-term commitment should be carefully evaluated.
